Acarix AB Stock OTC Markets
Stocks
ACIXF
SE0009268717
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
13:16:11 2026-08-07 EDT
|
5-day change | 1st Jan Change | ||
| 0.0280 USD | +1.13% |
|
0.00% | -8.05% |
| 08-13 | Acarix AB, Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 289M 30.52M 26.15M 24.46M 22.39M 42.03M 2.92B 42.58M 113M 1.47B 115M 112M 4.85B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 289M 30.52M 26.15M 24.46M 22.39M 42.03M 2.92B 42.58M 113M 1.47B 115M 112M 4.85B | EV / Sales 2026 * |
20.6x | EV / Sales 2027 * | 9.03x |
| Free-Float |
79.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Acarix AB
| 1 day | +1.13% | ||
| Current month | +28.44% | ||
| 1 month | +28.44% | ||
| 3 months | +19.66% | ||
| 6 months | -19.89% | ||
| Current year | -8.05% |
| 1 month | 0.03 | 0.03 | |
| Current year | 0.02 | 0.04 | |
| 1 year | 0.02 | 0.04 | |
| 3 years | 0.01 | 0.07 | |
| 5 years | 0.01 | 0.07 | |
| 10 years | 0.01 | 0.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aamir Mahmood
CEO | Chief Executive Officer | - | 2024-01-31 |
| Chief Executive Officer | 62 | 2018-02-22 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 2019-12-31 | |
Kenneth Nelson
BRD | Director/Board Member | 52 | 2024-05-13 |
Tony Das
BRD | Director/Board Member | - | 2024-05-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.13% | 0.00% | - | - | 30.63M | ||
| -0.84% | +3.92% | +28.04% | -29.04% | 18.11B | ||
| -3.05% | -7.40% | -38.72% | +93.72% | 1.69B | ||
| -0.74% | +3.08% | -42.56% | -80.75% | 1.02B | ||
| +1.26% | +0.44% | -21.55% | +28.94% | 985M | ||
| +0.11% | +0.11% | +63.23% | -6.33% | 779M | ||
| -2.29% | -1.45% | -36.91% | -46.86% | 704M | ||
| -1.91% | -12.67% | -44.02% | -44.74% | 577M | ||
| +3.23% | +2.36% | -39.55% | -34.64% | 443M | ||
| +3.19% | +6.69% | +77.41% | +50.00% | 428M | ||
| Average | +0.01% | -1.00% | -6.07% | -7.74% | 2.75B | |
| Weighted average by Cap. | -0.79% | +2.19% | +15.83% | -19.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14M 1.48M 1.27M 1.18M 1.08M 2.04M 141M 2.06M 5.46M 71.06M 5.55M 5.43M 235M | 32M 3.38M 2.89M 2.71M 2.48M 4.65M 323M 4.71M 12.48M 162M 12.69M 12.41M 537M |
| Net income | -30.8M -3.25M -2.79M -2.61M -2.39M -4.48M -311M -4.54M -12.01M -156M -12.21M -11.95M -517M | -15.3M -1.62M -1.38M -1.29M -1.19M -2.22M -155M -2.25M -5.97M -77.66M -6.07M -5.93M -257M |
| Net Debt | - | - |
Employees
8
Calendar
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACARIX Stock
- ACIXF Stock
Select your edition
All financial news and data tailored to specific country editions

















